Current status in lung transplantation: Patients, indications, techniques, and outcome;Aktuelles bei der lungentransplantation: Patienten, indikationen,techniken und ergebnisse

Medizinische Klinik

Volumn 97, Issue 3, 2002, Pages 137-143

  Fischer, Stefan ^a   Strüber, Martin ^a   Haverich, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Graft preservation; Immunosuppression; Ischemia reperfusion injury; Lung transplantation; Obliterative bronchiolitis; Techniques

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; EMPHYSEMA; HUMAN; LUNG FIBROSIS; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; MAJOR CLINICAL STUDY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PULMONARY HYPERTENSION; REOPERATION; REVIEW; SARCOIDOSIS; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; POSTOPERATIVE CARE; REOPERATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037087459     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-002-1137-9     Document Type: Review

References (51)

1. Lung transplant edema: Chest radiography after lung transplantation - The first 10 days
2. A prospective study of a quantitative PCR ELISA assay for the diagnosis of CMV pneumonia in lung and heart-transplant recipients
3. Double-lung transplant for advanced chronic obstructive disease
4. The impact of reperfusion injury on the long term development of obliterative bronchiolitis (OB) in lung transplantation
5. Successful double-lung transplantation with direct bronchial artery revascularization
6. Whence the lungs? A study to assess suitability of donor lungs for transplantation
7. Cell death in human lung transplantation: Apoptosis induction in human lungs during ischemia and after transplantation
8. Low-potassium dextran preservation solution improves lung function Aafter human lung transplantation
9. Raffinose improves lung preservation for 24 hours in low potassium dextran glucose solution: A histological and ultrastructural analysis
10. Raffinose improves the function of rat pulmonary grafts stored for 24 hours in low potassium dextran solution
11. Inhibition of angiotensin converting enzyme by captopril: A novel approach to reduce ischemia-reperfusion injury in lung transplantation
12. Giant cell interstitial pneumonitis: Disease recurrence in the transplanted lung
13. Immunosuppression in lung transplantation
14. Prevalence and outcome of invasive fungal infections in 1,953 thoracic organ transplant recipients: A multicenter retrospective study
15. Lung homo-transplantation in man
16. Twenty years of lung preservation - A review
17. Management of dysfunction in the transplanted lung: Experience with 7 clinical cases
18. The registry of the International Society for Heart and Lung Transplantation. 15th official report 1998
19. The registry of the International Society for Heart and Lung Transplantation. 16th official report 1999
20. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts
21. Operative technique for heart-lung transplantation
22. Sarcoidosis: Recurrence of primary disease in transplanted lungs
23. A method for safe twelve-hour pulmonary preservation
24. Improved lung preservation with dextran 40 is not mediated by a superoxide radical scavenging mechanism
25. The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation
26. Reperfusion edema after lung transplantation: Radiographic manifestations
27. Burkholderia cepacia. Management issues and new insights
28. The role of angiotensin converting enzyme in bronchiolitis obliterans: The antifibrotic effect of captopril
29. Lung transplantation: Current status and future prospects
30. Endothelial damage caused by ischemia and reperfusion and different ventilatory strategies in the lung
31. Temporary ECMO support following lung and heart-lung transplantation
32. Infectious complications of lung and heart-lung transplantation
33. Lymphangio-leiomyomatosis: Recurrence after lung transplantation
34. Seventy-two pulmonary retransplantations for obliterative bronchiolitis: Predictors of survival
35. Lung transplantation for end-stage pulmonary sarcoidosis
36. Improved technique for bilateral lung transplantation: Rationale and initial clinical experience
37. Airway complications
38. Indications. Unilateral, bilateral, heart-lung, and lobat transplant procedures
39. Airway revascularization: Is it necessary?
40. The international status of lung transplantation
41. Surgical treatment of airway complications after lung transplantation
42. Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function
43. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs
44. Experience with cyclosporine and steroids in clinical renal transplantation
45. Unilateral lung transplantation for pulmonary fibrosis
46. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ
47. Problems in the management of human lung transplant patients
48. Chronic rejection following lung transplantation. Incidence, time pattern and consequences
49. Alveolar epethelial fluid transport capacity in reperfusion lung injury transplantation
50. Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation?
51. Lung transplantation in patients with systemic diseases: An eleven-year experience at Papworth Hospital